Catherine Huck

807 total citations
6 papers, 27 citations indexed

About

Catherine Huck is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Catherine Huck has authored 6 papers receiving a total of 27 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Catherine Huck's work include Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Catherine Huck is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Catherine Huck collaborates with scholars based in Switzerland and United States. Catherine Huck's co-authors include Paul Smith, David Leppert, Gisbert Weckbecker, Robert R. Dunn, Francisco Córdoba, Frédéric Bornancin, Bruno Cenni, Enrico Ferrero, Diethilde Theil and Erik Wallstroem and has published in prestigious journals such as Neurology, Journal of Neuroinflammation and Journal of Neuroimmune Pharmacology.

In The Last Decade

Catherine Huck

6 papers receiving 27 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Huck Switzerland 3 15 13 6 5 5 6 27
Yinshui Chang Germany 4 12 0.8× 23 1.8× 2 0.3× 6 1.2× 7 1.4× 5 35
Sophy Denker Germany 4 23 1.5× 4 0.3× 10 1.7× 5 1.0× 20 4.0× 5 35
Olaf Behnke 2 15 1.0× 8 0.6× 4 0.7× 3 0.6× 6 1.2× 2 19
Sarah E. Davidson United Kingdom 4 8 0.5× 30 2.3× 6 1.0× 13 2.6× 7 1.4× 6 48
Lubomir Sokol United States 4 23 1.5× 12 0.9× 3 0.5× 3 0.6× 17 3.4× 8 42
Meredith Little United States 4 43 2.9× 24 1.8× 3 0.5× 6 1.2× 18 3.6× 8 67
Alina Fedorova Belarus 4 22 1.5× 10 0.8× 6 1.0× 3 0.6× 19 3.8× 8 37
Janina Schemme Germany 3 12 0.8× 6 0.5× 4 0.7× 13 2.6× 2 0.4× 4 32
Nusayhah Hudaa Gopee United Kingdom 2 9 0.6× 9 0.7× 3 0.5× 10 2.0× 11 2.2× 3 32
Hanna Weissbrot United States 3 15 1.0× 12 0.9× 4 0.7× 2 0.4× 3 0.6× 4 16

Countries citing papers authored by Catherine Huck

Since Specialization
Citations

This map shows the geographic impact of Catherine Huck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Huck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Huck more than expected).

Fields of papers citing papers by Catherine Huck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Huck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Huck. The network helps show where Catherine Huck may publish in the future.

Co-authorship network of co-authors of Catherine Huck

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Huck. A scholar is included among the top collaborators of Catherine Huck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Huck. Catherine Huck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Nuesslein‐Hildesheim, Barbara, Enrico Ferrero, Catherine Huck, et al.. (2023). Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis. Journal of Neuroinflammation. 20(1). 194–194. 9 indexed citations
2.
Huck, Catherine, et al.. (2019). Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates Neuroinflammation. Journal of Neuroimmune Pharmacology. 14(4). 709–719. 9 indexed citations
3.
4.
Smith, Paul, Catherine Huck, Diethilde Theil, et al.. (2017). Ofatumumab Differs from Rituximab by Effectively Targeting Lymph Node B cells and Achieving Faster Post-treatment Repletion (S24.003). Neurology. 88(16_supplement). 5 indexed citations
5.
6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yinshui Chang Breakdown of academic impact, for papers by Sophy Denker Breakdown of academic impact, for papers by Olaf Behnke Breakdown of academic impact, for papers by Sarah E. Davidson Breakdown of academic impact, for papers by Lubomir Sokol Breakdown of academic impact, for papers by Meredith Little Breakdown of academic impact, for papers by Alina Fedorova Breakdown of academic impact, for papers by Janina Schemme Breakdown of academic impact, for papers by Nusayhah Hudaa Gopee Breakdown of academic impact, for papers by Hanna Weissbrot
Rankless by CCL
2026